The batch is complete. The release record is not.
Manufacturing has finished, QC has results, and inventory remains quarantined. QA is still determining whether the executed process, approved specification, investigations, equipment state, material genealogy, documentation, and destination-market requirements form one coherent release case.
The delay is often treated as a reviewer-efficiency problem. It is more fundamental: the evidence was created in separate systems without a shared release plan or durable relationship to the decision it must support.
Release requirements begin before the batch
Product, strength, presentation, process version, site, market, specification, testing plan, sampling plan, regulatory commitments, certificate template, release role, and exceptional-release policy determine what must be true.
Seal resolves those requirements when the batch is planned. Each obligation has a source, effective version, expected evidence, owner, dependency, and completion rule. QA sees a live release case rather than inventing a checklist after manufacturing ends.
The release case is the accountable integration layer
MES remains authoritative for execution; LIMS for samples and approved results; QMS for investigations and quality decisions; equipment and training systems for their lifecycle records; inventory for physical status and location.
The release case references the exact records and versions used. It does not flatten all source data into a PDF or rely on links that always open the latest state.
Define the review population precisely
Batch, sublot, intermediate, bulk, packaging lot, component lots, samples, retests, reworks, campaign, equipment uses, rooms, operators, deviations, and shipments can all affect disposition.
Seal builds the candidate population from genealogy and execution, then lets the designated reviewer confirm exclusions or additions with rationale. A late-added sample or linked deviation reopens the affected review obligation.
Review the executed process against its approved state
Each operation retains instruction version, actual values, calculations, materials, equipment, user, time, signatures, conditional path, correction, and exception. Review compares actual execution with the requirements effective for that batch.
Missing signatures, skipped or repeated steps, out-of-range observations, unapproved substitutions, unresolved corrections, and unverified calculations become specific exceptions—not a red banner with no evidence path.
Results mean more than pass or fail
Release testing retains sample identity and custody, specification and method versions, instrument and acquisition, calculation, system suitability, result units, rounding, review, invalidation history, OOS or OOT context, and final approval.
The release obligation resolves only from the reportable approved result. A passing preliminary value cannot satisfy it, and an invalidated result cannot remain silently green in the batch view.
Specifications are effective by product, market, and date
The same batch may face different registered tests, limits, statements, or documents by destination. Seal resolves the applicable specification state rather than assuming one global table.
When a specification changes, historical batches retain the version actually used. Open release cases are assessed for impact under controlled change, not recalculated without review.
Exceptions retain their process context
A deviation links to the operation, material, equipment, person, process values, alarms, sample, and time window that produced it. The release reviewer sees containment, investigation status, product-impact assessment, disposition, CAPA, and any market consequence in the same context.
Closure of the deviation is not itself proof that the batch is releasable. The release decision records how the approved investigation conclusion affects this specific batch and population.
OOS, OOT, and atypical work remain visible
The original result, laboratory assessment, hypothesis testing, manufacturing investigation, retest or resample authorization, all generated data, final conclusion, product impact, and approvals remain linked.
Replacement results do not overwrite the event. Release policy determines whether the investigation must be closed, may remain open under an approved exception, or blocks disposition entirely.
Equipment and facility eligibility is point-in-time evidence
Qualification, calibration, maintenance, cleaning, line clearance, environmental state, alarm, and use history are evaluated at the time and purpose of use. Current-green status is not retroactive proof.
An overdue calibration discovered later opens an impact assessment against the affected uses. The batch review consumes that signed outcome rather than guessing from today's asset status.
Personnel eligibility is task specific
Training completion alone may not authorize every operation. Curriculum version, effective date, role, supervised practice, practical qualification, expiration, restriction, and temporary authorization can all matter.
Seal records the eligibility decision at execution and makes the underlying evidence available to release review. A later training update does not rewrite who was qualified when the work occurred.
Data review includes the systems around the record
Audit-trail review, source-data review, interface reconciliation, historian summaries, calculation verification, instrument-sequence review, missing-data checks, and electronic-
The reviewer sees the defined population, exceptions, reviewer, outcome, and evidence. “Audit trail reviewed” is not a checkbox detached from what was reviewed.
Review by exception still requires a known denominator
Automation can verify deterministic requirements and route unresolved items. The batch view shows completed obligations, open exceptions, excluded items, stale evidence, changed source records, and manual judgments.
Green means every required rule ran against the intended population and source version. It does not mean the system hid everything that was not red.
Concurrent review shortens the critical path safely
Manufacturing, QC, and QA can review completed evidence while later operations or tests continue. Each review records its scope and source versions. If relevant evidence changes, the affected approval becomes stale and returns to the queue.
Concurrent review changes when work happens, not what evidence or accountability is required. This is especially valuable for short-shelf-life products where post-completion compilation would consume material usable life.
Short-shelf-life release exposes time and uncertainty
For cell therapies, radiopharmaceuticals, some vaccines, and other time-critical products, the release plan models scheduled availability, latest acceptable decision time, missing results, conditional dependencies, handoffs, and contingency paths.
Any use of rapid, parametric, conditional, or exceptional release follows the approved product- and jurisdiction-
Manufacturer disposition and market eligibility are distinct
QA may approve a batch against manufacturer requirements while a destination still depends on authority lot release, market-specific approval, label state, import testing, serialization, or another regulatory gate.
Seal records the signed disposition and computes eligible product-market presentations separately. Inventory and distribution consume that state so “released” is never interpreted more broadly than the approved decision.
The disposition states exactly what was decided
Release, reject, reprocess, return, destruction, restricted use, further evaluation, and other configured decisions retain population, quantity, product state, markets, conditions, rationale, evidence snapshot, approvers, segregation-of-duty checks, signature meaning, and effective time.
Amendment or reversal creates a new decision linked to the prior state. The audit trail never turns a release into something that appears never to have happened.
CoA generation is downstream of approved truth
Certificate fields resolve from governed product, batch, specification, reportable results, method statements, manufacturing details, disposition, market, customer, and template versions. Every displayed value retains field-level provenance.
Generation, review, signature, delivery, correction, and replacement form their own document lifecycle. The CoA represents the release decision; creating the document does not make the decision.
Reconciliation closes the release case
Closure verifies all obligations, review populations, exceptions, investigations, results, signatures, market gates, inventory status changes, certificates, notifications, and retained evidence. Any approved open item retains owner, due date, control, and reopen condition.
For Batch 2847, Seal can reconstruct the planned requirements, actual execution, every source record and version reviewed, exceptions and impact decisions, QA disposition, eligible markets, inventory transition, and issued certificates. That is the release record—not a folder assembled afterward.

